
|Articles|May 12, 2004
Alfuzosin improves both LUTS and sexual function
A once-daily dose of the uroselective alpha-1 blocker alfuzosin (Uroxatral),10 mg, significantly reduces lower urinary tract symptoms and also appearsto have a substantial positive effect on sexual function, according to datafrom a multinational study.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
2
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
3
Optimizing care for men with overactive bladder, with Keith Xavier, MD
4
The UroOnc Minute: Navigating BCG Maintenance Therapy in NMIBC, With Mark D. Tyson, II, MD, MPH
5






